App downloads in the two industry-leading stores — Apple’s App Store and Google Play — rose by eight percent year-over-year for the third quarter of 2017 (http://dtn.fm/6PkB5), reaching a total of 26 billion people worldwide with new product downloads alone, according to industry analyst TechCrunch. The report cited data from App Annie showing that revenue from those apps reached a record $17 billion during the same period.

While investment in the pre-IPO game industry is dominated by individuals with large holdings and venture capital firms, SWRM’s focus on small app developer funding and marketing through its incubation and acceleration process establishes a means by which “regular” investors can join the activity.

AppSwarm’s business incubation is one of four revenue streams it identifies, including social game development (it currently lists five games under its banner, such as “Turtles, huh?”), casino- and movie-themed applications and technical expertise contracts. The company expects to report revenues of $6 million to $7 million by the end of 2018 (http://dtn.fm/6uADc).

Its expansion into business utility apps includes a PDF document scanner under its banner, as well as a letter of intent with mobile technology developer SinglePoint, Inc. (OTC: SING), announced in October 2017, by which SWRM intends to roll out cannabis industry-friendly mobile apps (http://dtn.fm/M1Vb8).

The two companies said they expect to have their first product out within the next three months. The service-based app will facilitate business-to-business and business-to-consumer networks under SinglePoint’s subsidiary SingleSeed, which is striving to carve out its own niche in the rapidly expanding cannabis market as legalization efforts continue their march through local and national government halls across the continent.

For more information, visit the company’s website at www.App-Swarm.com

Let us hear your thoughts: AppSwarm, Inc. Message Board

• Demand for improved body protection for military and civilian applications likely to rise
• HighCom’s patented body armor technology is unique in the industry
• 37% increase in HighCom revenues for H1 2017 over H1 2016

Law enforcement officers are on the frontline of crime fighting efforts throughout the United States, and, with the rise in police fatalities in recent years, body armor has become a critical issue. Fox News reported that, according to a register kept by the National Law Enforcement Officers Memorial Fund, 135 officers were killed in 2016, the highest number of fatalities in five years (http://dtn.fm/7Mchq). For the current year to date, there have been 111 deaths, down by 11 percent from 2016. However, even one firearm-related fatality is too much, and law enforcement agencies are committed to ensuring that their officers are protected at all times. HighCom Global Security, Inc. (OTC: HCGS) is at the forefront of officer protection efforts through its body armor development programs, which involve the design, development, testing and manufacture of protective equipment. The company has developed a range of over 20 NIJ-compliant hard and soft armor products.

On another front, HighCom has GSA approval to supply the U.S. government with protective equipment, and it played a significant role in providing body armor for U.S. troops deployed in Iraq and Afghanistan. Its patented BlastWrap® technology is not designed to entirely resist impacts or blasts, but to reduce the impact significantly.

The product has been engineered to remove most of the energy from an explosion. BlastWrap® products are made from two flexible films of material filled with blast weakening volcanic glass beads or other suitable materials and covered with an extinguishing coating. This design lessens the effect of a blast while eliminating fireballs or flame fronts associated with the blast. All of the company’s products are configured for specific applications, whether for military or civilian use. This innovative material can be used to custom make protective barriers for any application and as a stand-alone material for insulation, ballistic armor or packaging. It can be used to provide fire and blast protection by lining any area on board aircraft, vehicles and ships.

HighCom has an extensive range of body protective equipment in both hard and soft formats. Its Type IIA armor provides body protection against small firearms, while Type II is designed to withstand impacts from larger handguns. Type IIIA body armor is the type normally employed by law enforcement officers, as it provides effective protection against high-powered revolvers. Types III and IV, on the other hand, are used to protect personnel against rifle rounds. The company’s products are designed and manufactured to the highest standards. All of its helmets conform to U.S. military specifications and undergo ballistic testing according to the NIJ 0106.01 standard, enabling HighCom to warrant their reliability in all combat and tactical situations.

Apart from law enforcement agencies, the company also supplies the Departments of Defense and Homeland Security, correctional facilities and municipal authorities. It also sells equipment to other countries in Europe, South America, Asia, Africa and the Middle East.

The company posted excellent financial results for the first six months of 2017, reporting revenues of $2.6 million, an increase of 37 percent over the same period in 2016. With both military and security agencies continually looking to improve the level of protection for their personnel, HighCom is eminently qualified to rise to that challenge and continue its business growth.

For more information, visit the company’s website at www.HighComSecurity.com

Let us hear your thoughts: HighCom Global Security, Inc. Message Board

• Patent-pending breakthrough technology to extract oil
• Environmentally-friendly and cost effective process to extract heavy oil
• Owns and operates valuable, producing oil sands resources

For over a century, oil has been the lifeblood of the world economy. Even with the advent of new power sources, oil will continue to be an indispensable resource and remain an essential commodity for decades to come. To meet unquenchable demand, the world extracts unrefined crude oil that ranges in density and consistency from thin and light weight to a thick, semi-solid heavyweight oil. Light crude oil pumped from wells commands a higher price on commodity markets, because it produces a higher percentage of fuels when refined. Heavy crude is more expensive and difficult to produce, since it’s very thick and doesn’t flow easily to production wells. Heavy oil is found predominately in tar sands concentrated in North America.

Squeezing oil out of tar sand is an expensive, laborious process. Between two and four tons of tar sand and two to four barrels of water are used to produce a single barrel of oil. Rather than drilling for oil, enormous shovels carve out open pits in the tar sands, scoop out the greasy sand, then haul it to be processed. Mining tar sands and converting it to gasoline releases three times more carbon dioxide than typical oil production and dirties vast amounts of water. Only unrelenting need drives such an economically and environmentally costly process.

With patent-pending technologies, Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is economically extracting heavy oils from oil sands, oil shale deposits and shallow oil deposits. The environmentally-friendly system is a closed-loop, solvent-based process, which dramatically lowers cost per barrel of production, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand and can easily be deployed anywhere in the world to unlock heavy oil deposits.

Petroteq has successfully launched its first extraction plant, Asphalt Ridge, in Utah and intends to rapidly scale up capacity throughout the state, which has over 30 billion barrels of previously undeveloped but now economically recoverable oil. Independent engineering estimates project 139,539,001 standard tank barrels (STB) of bitumen in place at the Asphalt Ridge site, which equates to around 87 million barrels of oil equivalent (BOE). Asphalt Ridge is one of Utah’s eight major oil sands deposits.

The price of oil has fluctuated wildly over the last 20 years from around $18 a barrel in 1998 to over $157 in 2008 to about $56 a barrel today. At any price, oil is and will continue to be the lifeblood of the world. Petroteq Energy’s environmentally friendly, cost effective solution looks to be a welcome answer to producing oil in a cheaper and cleaner way.

For more information, visit the company’s website at www.Petroteq.energy

Let us hear your thoughts: Petroteq Energy Inc. Message Board

• IGC is scheduled to market a liquid formulation of its drug, IGC-AD1 (Hyalolex), in 2018; company is eyeing markets in Germany, Canada and U.S. states where licensed medical cannabis has been legalized
• IGC is exclusive licensee of a U.S. patent filing for possible THC-based Alzheimer’s disease (AD) therapy, which, if approved, could give it a huge advantage in competition for share of global drug market for AD
• Alzheimer’s Association: Some five million Americans have AD or some form of dementia, and $259 billion is being spent on treatments in 2017 — a number that could skyrocket to $1.1 trillion by 2050

India Globalization Capital, Inc. (NYSE American: IGC) sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex). It also sees the commercialization in 2018 of Hyalolex in a non-inebriating liquid supplement version. IGC has identified a number of U.S. states, as well as Canada and Germany, as target markets in the future.

The Maryland-based company is focused on the development of cannabis-based combination therapies to treat eating disorders, nausea, Alzheimer’s disease (AD), pain, and possibly Parkinson’s. It is also researching drugs that treat epilepsy in dogs and cats. The firm already has a portfolio of patent filings and four lead products that address these conditions.

IGC is the exclusive licensee of the U.S patent filing, “THC As A Potential Therapeutic Agent For Alzheimer’s Disease.” This gives IGC an advantage in the global market of AD drugs.

The global potential of AD treatment in massive. IGC sees worldwide application of its cannabinoid-based therapies (http://dtn.fm/3z2vD). In the U.S. alone, the Alzheimer’s Association estimates that treatment of AD and other forms of dementia will cost about $259 billion in 2017 — and that number could rise to $1.1 trillion by 2050 (http://dtn.fm/yTM4z). The Association said some five million Americans have AD today, and that number could rise to 16 million by 2050.

Because AD begins well prior to the appearance of symptoms, a drug such as IGC-AD1, which has shown an ability to lower production/aggregation of Aβ plaque without neurotoxic effects or inebriation, could be taken as a prophylactic treatment to prevent AD.

IGC has entered into a Memorandum of Understanding (MOU) with Hamburg, Germany-based MediCann Handels GMBH for the distribution of IGC’s cannabinoid-based therapies, including IGC-AD1, to pharmacies, apothecaries and other licensed outlets that can legally sell cannabinoid-based products (http://dtn.fm/t1Dg1). The MOU calls for MediCann to provide the capital required for the import, storage, transportation, sales and marketing of the products. In Germany, the number of dementia cases is 1.6 million-plus, most commonly caused by AD, per company data.

In a news release, Ram Mukunda, CEO of IGC, said the company would market, through medical dispensaries, a non-inebriating liquid supplement version of IGC-AD1 in 2018, with target markets spanning Germany, Canada and certain states within the U.S. Cumulatively, these markets have some 7.8 million patients with AD, the company said (http://dtn.fm/U0Cm8).

For more information, visit the company’s website at www.IGCinc.us

• Proprietary lipophilic enhancement technology boosts bioavailability of orally ingested cannabinoids and masks unpleasant taste
• Only company in the world to obtain a patent for improved oral or ingestible delivery of all cannabinoids, including both non-psychoactive and psychoactive
• Company generates revenue from out-licensing its technology

The cannabis market is exploding globally as well as domestically, and Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids—an advancement from which many cannabis-related companies can profit.

Lexaria’s proprietary lipophilic enhancement technology has demonstrated the ability to boost the bioavailability of all orally ingested cannabinoids. The body’s gastrointestinal tract poorly absorbs cannabinoids—whether ingested in pill form or via cannabis edibles—so smoking as a means of cannabis administration has been the norm for many users in order to achieve greater effectiveness. Lexaria’s technology, however, enables the body to derive greater effect from orally administered cannabinoids without the vehicle of smoking. The company’s patented process increases bio-absorption of cannabinoids by between five- and ten-fold and, additionally, reduces onset time by about 75 percent.

In addition to poor absorption, a second hindrance exists when it comes to orally administrated cannabis, and that is an unpleasant taste that accompanies it. Companies that manufacture edible cannabis products have been forced to mask this disagreeable attribute with an overabundance of sweeteners, which adds an unhealthy element to the products and still isn’t enough to completely subdue the repellent taste. Lexaria’s technology combats this problem by effectively and thoroughly masking the unpleasant flavor of cannabis.

The company’s lipophilic enhancement technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and it’s patent-allowed for tetrahydrocannabinol (THC) and all other psychoactive cannabinoids, as well as non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and more.

Lexaria is, to date, the only company in the world to be awarded a patent for the improved oral or ingestible delivery of all cannabinoids, including pill form, beverages and edibles. The company has patents relating to its technology in both the United States and Australia and, additionally, has a portfolio of 19 national and regional patent application filings in 44 other countries.

Lexaria generates revenue by out-licensing this technology and is positioned to now out-license it at a considerable royalty rate as a partner to biopharmaceutical companies rather than a competitor. The company foresees this generating substantial new business opportunities in 2018.

For more information, visit the company’s website at www.LexariaBioscience.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• GOHE at vanguard of explosive FinTech industry growth
• Guided by nearly 100 years of executive talent and experience
• Proprietary state-of-the art systems position GOHE for significant footprint

Founded in 2009 with a focus on prepaid debit cards and electronic wallets, Global Payout, Inc. (OTC: GOHE) has deftly evolved into a full service payment platform that delivers complete customizable payment solutions for almost any entity engaged in domestic or international financial transactions. A leader in the booming FinTech industry, Global Payout has distinguished itself as a premier global provider of payment and disbursement services to unbanked, underbanked and bank adverse customers. Visionary, experienced management navigated the company’s successful evolution into the global player it is today in the booming FinTech industry.

Founder James Hancock, CEO and chairman of the board of Global Payout, has over thirty years’ experience in multiple executive capacities in financial services, investment banking, mergers and acquisitions, telecommunications and payment processing. Prior to founding Global Payout, Hancock, who holds a Juris Doctorate from the California School of Law, specialized in the financial services sector for 14 years and launched nearly 40 custom-designed prepaid debit card programs. Operating as a prepaid card services company, Hancock soon realized by listening to Global Payout’s customers the need and opportunity for comprehensive and customizable global payment solutions. His business acumen and prescience led to the development of Global Payout’s proprietary Global Reserve Platform (GRP), now recognized as one of the most powerful, customizable and extensible platforms available to provide B2B solutions for the automation of international funds transfer, payments, billing and invoicing processes.

Successfully managing such a significant corporate transition from prepaid cards to global payment solutions is a daunting endeavor, and Hancock recruited exceptional talent to achieve and exceed his goals. William Rochfort, president, board member and VP of sales and marketing, has over 25 years’ experience in leadership roles at various national start-ups and global companies. He built and nurtured top-end sales and tech-support divisions in network services and managed over 350 direct sales and technical support teams that exceeded $200 million in annual sales revenue. At Global Payout, Rochfort has established international sales and marketing channels for both direct and indirect sales, as well as a network of international distributors, channel partners and value-added resellers. He is focused on continued global expansion and is responsible for web-based services and supporting personnel.

With a strong background in the financial markets, Joseph Sebo, CFO and board member, joined the company in 2010. His responsibilities include financial reporting and transparency, public company compliance, investor relations, SarbanesOxley compliance and serving as controller and treasurer. With broad experience in publicly traded companies and investment banking, Sebo was instrumental in up-listing Global Payout in the over-the-counter markets.

With resolution and vision, Hancock has successfully transformed Global Payout’s core business model while assembling nearly a century of collective knowledge and experience on the senior management team. With such a track record and talent, it’s hard to imagine that Global Payout won’t achieve a significant footprint in the burgeoning global FinTech markets.

For more information, visit the company’s website at www.GlobalPayout.com

Let us hear your thoughts: Global Payout, Inc. Message Board

• LEI number is equivalent to a barcode and The European Union requires it to identify financial market participants, such as banks and investment funds
• German Stock Exchanges (Frankfurt Stock Exchange) mandate that LEI numbers are required by January 3, 2018 for all listed companies
• 92 Resources Corp. is a Vancouver, Canada-based emerging junior exploration company that owns six sites in Canada

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) announced that it has been assigned a Legal Entity Identifier (“LEI”) number (http://dtn.fm/EHx1n). It is significant because the European Union has adopted regulations that require use of the LEI as an equivalent to a barcode, pinpointing systematic risks.

This 20-digit alphanumeric code is both an internationally standardized and globally valid identifier for financial market participants. Its purpose is to clearly identify contracting parties, such as investment funds, banks, and other companies. It is also used to comply with a number of financial reporting requirements.

92 Resources is a Vancouver-based emerging junior exploration company focused on acquiring and advancing strategic and prospective assets to the benefits of its shareholders, targeting primarily modern energy-related projects. 92 Resources owns six properties in Canada, with its three principal assets being the Hidden Lake Lithium Property in the Northwest Territories, the Corvette Lithium Property, QC, and the Golden Frac Sand Property, BC.

92 Resources now meets the requirements of the Frankfurt Stock Exchange to have an LEI number by January 3, 2018. “The LEI will clearly assist the regulatory authorities in monitoring and analyzing threats to the stability of the financial markets (but) it can also be utilized by counter parties internally for risk management purposes,” the Deutsche Borse Group stated. It added on its website that the LEI number will affect most aspects of the securities markets in Europe (http://dtn.fm/WO0Ep). These include clearing, trading, settlement, collateral, custody, and liquidity management.

For more information, visit the company’s website at www.92Resources.com

Let us hear your thoughts: 92 Resources Corp. Message Board

• The rapid growth of the legal cannabis industry has increased the need for tailored and comprehensive payment solutions for dispensaries and other retailers in the field.
• Medical Cannabis Payment Solutions partnered up with First Bitcoin Capital Corporation to enable cryptocurrency payments.
• The company has also launched its specialized digital payment platform for dispensaries that ensures full compliance and delivers full-spectrum merchant processing services.

Medical Cannabis Payment Solutions (OTC: REFG) announced that it will integrate First Bitcoin cryptocurrency (“$Weed”) with its StateSourced medical cannabis payment gateway service. The announcement came in November, following a partnership agreement between Medical Cannabis Payment Solutions and First Bitcoin Capital Corporation (OTC: BITCF).

Medical Cannabis Payment Solutions is an industry leader in the field of payment processing for the marijuana industry. Currently, no other company on the market offers a completely integrated payment processing system that’s entirely tailored to the needs of marijuana industry representatives. The company helps rapidly growing businesses in the field by identifying tools that dispensaries need the most and customizing these tools to address the operational specifics in the field.

The partnerships with First Bitcoin Capital Corporation is yet another move in the same direction. Through the collaboration, dispensaries and other companies that work in the marijuana industry will gain another opportunity for payment processing. They will work with both debit cards and prominent cryptocurrencies like $Weed and the well-known bitcoin.

Medical Cannabis Payment Solutions and First Bitcoin Capital Corporation signed a partnership agreement on November 8, 2017. The aim of the agreement is to revolutionize end-to-end compliance solutions. Upon the complete realization of the new project, a platform will be launched to deploy an exchange system. Because of the growing cannabis industry, more flexibility is required in terms of payment processing. The addition of a decentralized cryptocurrency provides an easy opportunity for non-cash payments to be made.

According to Medical Cannabis Payment Solutions representatives, the partnership will enable consumers to overcome many of the regulatory obstacles in the industry. As a part of the project execution, the company has announced that it will buy a block of $Weed in return for a block of REFG restricted common stock.

First Bitcoin Capital Corporation CEO Greg Rubin said that America is shaping up to be one of the world’s biggest marketplaces for the products of the cannabis industry. The partnership with Medical Cannabis Payment Solutions can potentially revolutionize compliance products and the processing of payments in the field.

America’s medical cannabis industry is expected to grow at double digit rates in the years to come. According to a Bloomberg report, the compound annual growth rate will be 27 percent by 2021 (http://dtn.fm/z6yL7). In 2016 alone, consumers spent 6.7 billion dollars on legalized weed products. The increase is 34 percent on an annual basis.

By 2020, the marijuana industry is projected to create more jobs than manufacturing (http://dtn.fm/kv5Ny). Medical marijuana sales are set to increase from 4.7 billion dollars in 2016 to 13.3 billion dollars 2020. Recreational sales will go up from 2.6 billion dollars in 2016 to 11.2 billion dollars in 2020.

With growing trends towards widespread legalization, Medical Cannabis Payment Solutions announced the launch of the first in-market digital payment solution in November 2017. The product is specially tailored to the needs of dispensaries. The payment solution can track sales, it features encrypted digital security and allows for comprehensive client management.

For more information, visit the company’s website at www.MedicalCannabisPaymentSolutions.com

Let us hear your thoughts: Medical Cannabis Payment Solutions Message Board

• OptHemp Product Line successfully launched on Amazon and Alibaba
• CBD Magic Hemp Series generated 40,000 views and the purchase of over 91 units just minutes into launch
• CIIX offering is an innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s booming skin care market

ChineseInvestors.com, Inc. (OTCQB: CIIX), in partnership with its foreign enterprise, CBD Biotechnology Co. Ltd. and through its subsidiary ChineseHempOil.com, Inc. has successfully launched its OptHemp product Line via a Top 100 platinum level seller on Amazon.com (NASDAQ: AMZN) and on China’s largest e-commerce retailer Alibaba. During its debut broadcast of “China Taobao Live Broadcasting Celebrity Show,” the company’s “CBD Magic Hemp Series” generated 40,000 views and the purchase of over 91 units just minutes into launch. ChineseInvestors.com CEO Warren Wang indicated in the news release that the product line’s successful initial launch on Taobao “solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin.”

According to Markets Insider (http://dtn.fm/rE7zR), the CBD Magic Hemp Series is the company’s first line of hemp-infused skin care products (the CBDBIO TECH Brightening and Refreshing Moisturizer, CBDBIO TECH Perfecting Shield Primer and CBDBIO TECH Peptide Collagen Solution).  The products are intended to bring a moisturizing balance, form a protective layer, provide an even skin tone, and firm the skin while reducing the signs of aging. Different from other skin care lines currently available in China, the products are infused with non-industrial cannabidiol or CBD. While CBD, known as a powerful antioxidant and anti-inflammatory agent, has been widely used in skin care products in western countries for some time, its groundbreaking use in CBD Magic Hemp Series positions the innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s skin care industry.

This product launch and debut with CBD products positions CIIX as an emerging leader in a strong market segment. According to CBD Biotechnology and as reported by Fidelity Investments (http://dtn.fm/SvQY4): “China has one of the world’s largest consumer markets for skin care products. Retail sales of skincare products and make-up products in China reached 169.1 billion yuan and 28.3 billion yuan respectively in 2016, with year-over-year growth of 5% and 12% respectively. Skin care is expected to reach 223.3 billion yuan in 2021 with growth driven by rising awareness of skin health and consumption upgrading Chinese consumers.  As one of the first hemp infused skin care brands in China, we are confident that CBD Biotechnology will lead Chinese market, with potential for global expansion.”

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Company expects $9.6 million in revenues for first 12 months operating its health care services division
• Launching animal waste product in 4Q2017 aimed at offering improved environmental sustainability
• Forecasts 50 percent YOY growth for home interiors subsidiary in 2017

What do the health care, eco-friendly, and construction industries have in common? Start with their ability to generate a return on investment when a savvy partner is involved, and you don’t have to think too hard about the rest.

RJD Green Inc.’s (OTC: RJDG) merger and acquisition strategy places an emphasis on buying, partnering or entering joint ventures with companies that have a vibrant presence in any of the three above-identified market niches, and then helping those businesses maximize their profits and corporate quality. The company looks for long-term staying power, geographic reach and the capacity to expand into further markets. Its acquisition sights are set on companies with between $5 million and $40 million in yearly revenues. Those benchmarks help shareholders measure the potential for a return on their investments.

The RJD Green health care services branch specifically supports the medical billing market with proprietary software and IT services that help streamline electronic payment processing. Its IoSoft Inc. system has been integrated by Blue Cross, Aetna, CIGNA and other medical insurance providers.

“From ongoing negotiations that are occurring now, we expect to see more accelerated monthly contracts procured in the first calendar quarter of 2018,” IoSoft President Vincent Valentine stated in a September news release.

The company’s health care services division has already established eight new contracts that are expected to launch across the fourth quarter of 2017 and the first quarter of 2018, as further indicated in the release. The announcement resulted in a 12-month revenue forecast of $9.6 million.

RJDG’s Earthlinc Environmental Solutions subsidiary focuses on bringing environment-supporting technologies to market for both corporate and small-business needs, beginning with Animal Waste Management’s solutions to commercial poultry and hog industry challenges.

RJDG’s Silex Holdings targets building material products and services that are positioned to offer immediate growth in a unique geographic market, beginning with the production of counter tops, cabinets and related kitchen and bath products. Silex Interiors fills a market niche between retailers like Home Depot and local contractors that use their products, and the company has forecast revenue and profit growth of 50 percent over the previous year by the end of 2017.

Silex Interiors can operate at least four corporate locations and 12 to 18 franchises nationwide. Through such diversity of interests, RJD Green ensures its potential for sustainability and vitality in an often-challenging marketplace.

For more information, visit the company’s website at www.RJDGreen.com

Let us hear your thoughts: RJD Green Inc. Message Board